Diabetes

Trends in Insulin Out-of-Pocket Costs and Use Disparities, 2008-2021

August 4th 2025

Adults with type 2 diabetes, especially those in vulnerable groups, face higher risks of medical debt, low credit scores, and bankruptcy.

By Elise S. Tremblay, MD, MPH
Stephanie Argetsinger, MS, MPH

July 31st 2025

PFAS | Image credit: Vodkaz - stock.adobe.com

PFAS Exposure Linked to Increased Risk of Type 2 Diabetes, Study Finds

SGLT2i-Induced Erythrocytosis Not Linked to Clots in Type 2 Diabetes

July 29th 2025

Diabetes monitoring | Image credit: abidika - stock.adobe.com

Semaglutide, Tirzepatide Cut Dementia, Stroke Risk in Type 2 Diabetes

July 21st 2025

MRI head brain scan - DedMityay - stock.adobe.com

1 Credit / Cardiology, Neurology

July 18th 2025

Advancing Care in Type 2 Diabetes and Obesity: A Coordinated, Guideline-Driven Approach

Understand how recent advances in GLP-1 receptor agonists and other therapies are transforming the treatment of type 2 diabetes and obesity through a shift of reactive to proactive care that addresses root causes of cardiometabolic disease.

Watch Now

Continuing Medical Education

View All

August 6th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

August 6th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

October 13th 2015

Glass of Red Wine Won't Hurt Those With Diabetes, and May Help

After 2 years, those drinking red wine had improved "good" cholesterol and other benefits.

October 12th 2015

Fraud or Poverty? What Accounts for High Medicare Spending?

A new report found that while geographic gaps narrowed, they will likely persist because state policies to not expand Medicaid will mean the poor will continue to turn 65 with health issues having gone unaddressed.

October 9th 2015

5 Things to Know About the New Cholesterol Drugs

With Express Scripts' coverage starting Monday, here's some background on Praluent and Repatha.

October 8th 2015

Cost of Kidney Failure Next in CMS' Crosshairs With New ACO Model

Taking aim at payment models for patients on dialysis is the latest attempt to target high-cost areas of Medicare spending.

October 8th 2015

Food Politics Get Heated as Dietary Guidelines Near Approval

Intense lobbying and charges of bias surround the late efforts to influence what goes into the 2015 Dietary Guidelines for Americans. A recommendation from an advisory committee to eat less red and processed meat has fueled most of the controversy.

October 7th 2015

Express Scripts Will Cover Both PCSK9 Inhibitors

The PBM declined to list what discounts it had negotiated, but said it expected to spend $750 million on this cholesterol-lowering class in 2016.

October 6th 2015

Arizona Report Highlights Obesity Crisis Among Native Americans

AJMC Staff

The recent overview of obesity from the Trust for America's Health revealed extremely high percentages of Native Americans are overweight and obese, especially in states where they live in remote locations.

October 5th 2015

Weight-Loss Surgery Can Prevent Cancer, Now Let's Pay for It

The evidence of weight-loss improving overall well-being and predisposition to chronic as well as acute conditions is mounting. We now need coverage policies that can help patients take advantage of weight loss procedures.

October 5th 2015

Managing Repatha and Praluent Could Be a Walk in the Park for Health Plans

Thomas Morrow, MD

The PCSK9 drugs are stirring up a lot of attention, primarily around how to restrict access. But, no one is talking about how to best manage the patient's needs.

October 2nd 2015

Access to Palliative Care Remains an Issue in US Hospitals

A study reports that despite the steady growth in hospital-based palliative care programs, access is sketchy and is driven by geographic location and hospital ownership.

October 2nd 2015

Technique Allows Scientists to Create Insulin-Producing Cells

The technique deploys several strategies to reduce cancer risk. It is being evaluated in mouse models but researchers are already looking ahead to human studies.

October 1st 2015

Utah Providers: Too Much of Medicaid Tax Falls on Us

An earlier plan from Governor Gary Herbert that was paid for with existing state funds was rejected by the legislature. The current plan would add 95,000 Utahns to Medicaid, with hospitals paying most of the state's share after 2017.

October 1st 2015

Severely Obese Children Face Higher Risk of Diabetes, Heart Disease, Study Finds

AJMC Staff

Researchers say the results may help physicians better target screening for obese youth.

September 30th 2015

Model Predicts Healthcare Utilization With EMR Information

Laura Joszt, MA

Researchers in China and the United States have developed a predictive model capable of forecasting which patients will account for either small or large proportions of healthcare resource utilization in the next 6 months.

September 30th 2015

Type 2 Diabetes Remission More Likely After Gastric Bypass, Sleeve Than Banding, Study Finds

All 3 methods caused patients to lose weight, but 2 were more likely to produce remission in type 2 diabetes.

September 30th 2015

Conflict of Interest Rampant in Academic-Industry Partnerships

A study published in BMJ measured the prevalence, annual compensation, and beneficial stock ownership of directors from publicly traded healthcare companies who had academic affiliations.

September 30th 2015

A Randomized Controlled Trial of Negative Co-Payments: The CHORD Trial

Kevin G. Volpp, MD, PhD Andrea B. Troxel, ScD Judith A. Long, MD Said A. Ibrahim, MD, MPH Dina Appleby, MS J. Otis Smith, EdD Jalpa A. Doshi, PhD Jane Jaskowiak, BSN, RN Marie Helweg-Larsen, PhD Stephen E. Kimmel, MD, MSCE

This study extends value-based insurance design concepts in testing the impact on blood pressure control of rewards that provided negative co-payments for blood pressure medication.

September 30th 2015

A Randomized Controlled Trial of Co-Payment Elimination: The CHORD Trial

Kevin G. Volpp, MD, PhD Andrea B. Troxel, ScD Judith A. Long, MD Said A. Ibrahim, MD, MPH Dina Appleby, MS J. Otis Smith, EdD Jane Jaskowiak, BSN, RN Marie Helweg-Larsen, PhD Jalpa A. Doshi, PhD Stephen E. Kimmel, MD, MSCE

This study tests the impact on blood pressure control of a reward that lowered co-payments for blood pressure medication to $0.

September 29th 2015

Lixisenatide New Drug Application Accepted for Review With CV Results Already in Hand

Results presented at the American Diabetes Association in June showed no CV risk or benefit and no risk of pancreatic injury, an issue that has been of particular concern to FDA.

September 28th 2015

Behavioral Health at Heart of Recommended Medicaid Measures From National Quality Forum

The recommendations for improving quality care in Medicaid track recent trends in psychiatric and diabetes care, which recognize the connection between physical and mental health.

September 28th 2015

Medtronic Announces US Availability of MiniMed Connect Technology

The technology was approved by FDA in June and unveiled at the Scientific Sessions of the American Diabetes Association.

September 28th 2015

Diabetes: The Next Healthcare Tsunami

Brenda Schmidt

Eighty-six million US adults are at high risk of developing type 2 diabetes. Without prevention, there will be a drastic increase in the number of Americans who will develop type 2 diabetes.

September 25th 2015

Dexcom G5 Mobile CGM System Approved by FDA

Synjardy Joins Ranks of Combo Therapies for T2DM

September 25th 2015

Outlook Changing in Payer Coverage for Obesity Medications, Commentators Say

September 25th 2015

Many hoped the 2013 declaration by the American Medical Association that obesity is a disease would open the door for payer coverage of pharmacotherapy to treat it. While that did not happen right way, a new commentary in Evidence-Based Diabetes Management by Ted Kyle, RPh, MBA, and Fatima Cody Stanford, MD, MPH, MPA, outlines how the tide appears to be turning for coverage of evidence-based treatment.

September 25th 2015

Joslin Diabetes Center Taps Amenta as New President & CEO

Peter S. Amenta, MD, PhD, spent 8 years as the dean of Rutgers Robert Wood Johnson Medical School during a period of tremendous growth and change.

September 24th 2015

Empagliflozin Is First Diabetes Drug to Hit "Holy Grail" of Cutting Heart Attack, Stroke Deaths in Clinical Trial

Blood Pressure Medication at Night Lowers Diabetes Risk, Studies Say

September 24th 2015

The research by the group from Spain is the latest effort to link sleep patterns, or disruption of sleep, to the development of type 2 diabetes.

September 23rd 2015

Fingernail Tests May Offer Cheap, Simple Way to Diagnose Diabetes

Fingernail tests could offer a solution to diabetes testing in the developing world, and a faster test for gestational diabetes could diagnose this condition earlier in pregnancy.

September 23rd 2015

Dissecting the Patient Perception of FDA's Breakthrough Designation